Paper30515134
Selective Targeting of 4SO4-N-Acetyl-Galactosamine Functionalized Mycobacterium tuberculosis Protein Loaded Chitosan Nanoparticle to Macrophages: Correlation With Activation of Immune System.
Mubin N and 3 others. Front Microbiol, 2018. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Selective Targeting of 4SO4-N-Acetyl-Galactosamine Functionalized Mycobacterium tuberculosis Protein Loaded Chitosan Nanoparticle to Macrophages: Correlation With Activation of Immune System. Papers, record 30515134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30515134
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Selective Targeting of 4SO4-N-Acetyl-Galactosamine Functionalized Mycobacterium tuberculosis Protein Loaded Chitosan Nanoparticle to Macrophages: Correlation With Activation of Immune System.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 33552031 | Corrigendum: Selective Targeting of 4SO4-N-Acetyl-Galactosamine Functionalized Mycobacterium tuberculosis Protein Loaded Chitosan Nanoparticle to Macrophages: Correlation With Activation of Immune System. | https://conductscience.org/library/papers/33552031 |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21376383 | Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. | Cell | 2011 | https://conductscience.org/library/papers/21376383 | PubMed |
| 2 | 12760874 | High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12760874 | PubMed |
| 3 | 23228812 | Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system. | Vaccine | 2013 | https://conductscience.org/library/papers/23228812 | PubMed |
| 4 | 1279438 | Engineering galactose-binding activity into a C-type mannose-binding protein. | Nature | 1992 | https://conductscience.org/library/papers/1279438 | PubMed |
| 5 | 21339647 | Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21339647 | PubMed |
| 6 | 28933147 | Antimicrobial Chitosan and Chitosan Derivatives: A Review of the Structure-Activity Relationship. | Biomacromolecules | 2017 | https://conductscience.org/library/papers/28933147 | PubMed |
| 7 | 2118680 | The minimal number of class II MHC-antigen complexes needed for T cell activation. | Science | 1990 | https://conductscience.org/library/papers/2118680 | PubMed |
| 8 | 15737546 | Cytotoxicity characterization of catanionic vesicles in RAW 264.7 murine macrophage-like cells. | Colloids Surf B Biointerfaces | 2005 | https://conductscience.org/library/papers/15737546 | PubMed |
| 9 | 19261352 | The many niches and strategies used by pathogenic mycobacteria for survival within host macrophages. | Immunobiology | 2009 | https://conductscience.org/library/papers/19261352 | PubMed |
| 10 | 15653305 | Ligand recognition by antigen-presenting cell C-type lectin receptors. | Curr Opin Immunol | 2005 | https://conductscience.org/library/papers/15653305 | PubMed |
| 11 | 16418529 | Real-time PCR in clinical microbiology: applications for routine laboratory testing. | Clin Microbiol Rev | 2006 | https://conductscience.org/library/papers/16418529 | PubMed |
| 12 | 14606868 | Chitosan as antimicrobial agent: applications and mode of action. | Biomacromolecules | 2003 | https://conductscience.org/library/papers/14606868 | PubMed |
| 13 | 20933470 | Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors. | Tuberculosis (Edinb) | 2010 | https://conductscience.org/library/papers/20933470 | PubMed |
| 14 | 20138662 | Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. | Biomaterials | 2010 | https://conductscience.org/library/papers/20138662 | PubMed |
| 15 | 15318216 | Direct evidence for atomic defects in graphene layers. | Nature | 2004 | https://conductscience.org/library/papers/15318216 | PubMed |
| 16 | 27512905 | Mycobacterial Acid Tolerance Enables Phagolysosomal Survival and Establishment of Tuberculous Infection In Vivo. | Cell Host Microbe | 2016 | https://conductscience.org/library/papers/27512905 | PubMed |
| 17 | 11168781 | Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. | J Intern Med | 2001 | https://conductscience.org/library/papers/11168781 | PubMed |
| 18 | 24102208 | State of the art and future directions in nanomedicine for tuberculosis. | Expert Opin Drug Deliv | 2013 | https://conductscience.org/library/papers/24102208 | PubMed |
| 19 | 16138384 | Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. | Angew Chem Int Ed Engl | 2005 | https://conductscience.org/library/papers/16138384 | PubMed |
| 20 | 8251442 | Characterization of chitosan. Influence of ionic strength and degree of acetylation on chain expansion. | Int J Biol Macromol | 1993 | https://conductscience.org/library/papers/8251442 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40148661 | Alleviation of mycobacterial infection by impairing motility and biofilm formation via natural and synthetic molecules. | World J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/40148661 | PubMed |
| 36203881 | Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages. | Adv Ther (Weinh) | 2022 | https://conductscience.org/library/papers/36203881 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30515134
GET https://conductscience.org/api/papers/v1/30515134/references?page=2